search
Back to results

Ischia Spinous Fascia Fixation Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Pelvic Organ Prolapse Stage III

Primary Purpose

Pelvic Organ Prolapse

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ischia spinous fascia fixation
Modified Pelvic Floor Reconstruction Surgery with Mesh
polypropylene mesh(Gynemesh)
Sponsored by
Peking Union Medical College Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring Stage III

Eligibility Criteria

55 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Candidates with symptomatic pelvic organ prolapse of POP-Q Stage III, suitable for surgical repair.
  • Vaginal hysterectomy and anti-incontinence procedures could be performed concurrently.
  • Age ≥ 55 years.
  • Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires.

Exclusion Criteria:

  • Previous repair of pelvic organ prolapse involving insertion of mesh.
  • Experimental drug or experimental medical device within 3 months prior to the planned procedure.
  • Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared.
  • Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery.
  • History of chemotherapy or pelvic radiation therapy.
  • Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease, multiple sclerosis, spinal cord injury or trauma).
  • Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis, endometriosis, coccydynia, vulvodynia).
  • Nursing or pregnant or intends future pregnancy.
  • Chronic cough not well-controlled.
  • BMI ≥ 30.
  • In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.

Sites / Locations

  • Foshan Maternal and Child Health HospitalRecruiting
  • Peking University Shenzhen HospitalRecruiting
  • the Third Affiliated Hospital of Zhengzhou UniversityRecruiting
  • Affiliated Shengjing Hospital of China Medical UniversityRecruiting
  • Peking Union Medical College HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

fascia fixation group

mesh group

Arm Description

procedure: ischia spinous fascia fixation

Procedure: Modified Pelvic Floor Reconstruction Surgery with mesh

Outcomes

Primary Outcome Measures

•Anatomical improvement according to POP-Q score.
•Anatomical improvement according to POP-Q score.
•Anatomical improvement according to POP-Q score.
•Anatomical improvement according to POP-Q score.

Secondary Outcome Measures

•Hospital data including operative time, estimated blood loss, length of stay, maximum temperature, time of voiding recovery.
•Pain score measured using Visual Analog Scale (VAS).
•Presence/absence of complications (composite score).
The occurrence (in the per-operative phase or within 6 weeks post-op) of at least one of the following: 1) bleeding complications; 2) infectious complications; 3) any wound caused by a surgeon movement: bladder, ureteral, or vascular injuries; 4)medical complications: deep vein thrombosis, pulmonary embolism and etc.Complications will be categorized using the Dindo surgical complication grading scale.
•Change from baseline in PFIQ-7 scores.
•In subjects sexually active at baseline, assessment of sexual function using PISQ-12 (mean scores and change from baseline)
•Subject global impression assessed on a 5 point Likert scale
•Presence/absence of complications (composite score)
Long-term negative outcomes of the surgical procedure will also be recorded until 3 years after surgery. For example, mesh erosion, de novo urinary incontinence, de novo dyspareunia and overall failure rate. Complications will be categorized using the Dindo surgical complication grading scale.

Full Information

First Posted
February 22, 2012
Last Updated
August 18, 2012
Sponsor
Peking Union Medical College Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01670682
Brief Title
Ischia Spinous Fascia Fixation Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Pelvic Organ Prolapse Stage III
Official Title
A Prospective,Multicenter Pilot Study to Compare Ischia Spinous Fascia Fixation Procedure With Modified Total Pelvic Floor Reconstruction Surgery For Pelvic Organ Prolapse Stage III
Study Type
Interventional

2. Study Status

Record Verification Date
August 2012
Overall Recruitment Status
Unknown status
Study Start Date
August 2012 (undefined)
Primary Completion Date
August 2016 (Anticipated)
Study Completion Date
August 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Peking Union Medical College Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Pelvic organ prolapse is a common problem. The primary treatment is surgery. Ischia spinous fascia fixation procedure and modified total pelvic floor reconstructive surgery with mesh are both developed in China for vaginal apex fixation, the former is native tissue repairs, and the latter is augmentation with mesh. This study is designed to determine the effectiveness and safety of ischia spinous fascia fixation procedure compared with modified total pelvic floor reconstructive surgery with mesh for the treatment of pelvic organ prolapse stage III. Patients enrolled into the study will be followed up for up to 3 years after surgery. Evaluation will take place during surgery and postoperative visit. Stage of prolapse before and after surgery, patient satisfaction through quality of life and sexual function questionnaires before and after surgery, and peri-operative complication rates will be evaluated.
Detailed Description
Pelvic Organ prolapse (a feeling of bulge in the vagina) may cause some distressing symptoms such as loss of control of the bowel or bladder, and may also cause problems with patient's sex life. An ideal procedure for vaginal apical support should provide a durable suspension, have minimal complications, and not affect sexual or visceral function. Vaginal procedures used for restoring the vaginal apex support include Ischia spinous fascia fixation procedure with native tissue and modified total pelvic floor reconstructive surgery with mesh. They are both developed and popular in China. Clinical practice showed that they were both safe, efficient and cost-effective. Recurrent rates of both procedures after 1 year follow-up were about 10%, and quality of life improved significantly from the baseline, while the.complications are different. The purpose of this multicenter, prospective, and comparative study is to evaluate the effectiveness and safety of these two procedures in the treatment of symptomatic pelvic organ prolapse Stage III in China.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
Stage III

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
fascia fixation group
Arm Type
Active Comparator
Arm Description
procedure: ischia spinous fascia fixation
Arm Title
mesh group
Arm Type
Active Comparator
Arm Description
Procedure: Modified Pelvic Floor Reconstruction Surgery with mesh
Intervention Type
Procedure
Intervention Name(s)
ischia spinous fascia fixation
Intervention Description
Subjects of this group were submitted to surgical treatment with ischia spinous fascia fixation.
Intervention Type
Procedure
Intervention Name(s)
Modified Pelvic Floor Reconstruction Surgery with Mesh
Intervention Description
Subjects of this group were submitted to surgical treatment with Modified Total Pelvic Floor Reconstruction Surgery with Mesh.
Intervention Type
Device
Intervention Name(s)
polypropylene mesh(Gynemesh)
Intervention Description
Pelvic floor reconstruction will be conducted using surgical mesh made from polypropylene.
Primary Outcome Measure Information:
Title
•Anatomical improvement according to POP-Q score.
Time Frame
6 weeks
Title
•Anatomical improvement according to POP-Q score.
Time Frame
1 year
Title
•Anatomical improvement according to POP-Q score.
Time Frame
2 years
Title
•Anatomical improvement according to POP-Q score.
Time Frame
3 years
Secondary Outcome Measure Information:
Title
•Hospital data including operative time, estimated blood loss, length of stay, maximum temperature, time of voiding recovery.
Time Frame
At discharge, an expected average of 5 days after operation.
Title
•Pain score measured using Visual Analog Scale (VAS).
Time Frame
24 hours post surgery and at the 6-week visit
Title
•Presence/absence of complications (composite score).
Description
The occurrence (in the per-operative phase or within 6 weeks post-op) of at least one of the following: 1) bleeding complications; 2) infectious complications; 3) any wound caused by a surgeon movement: bladder, ureteral, or vascular injuries; 4)medical complications: deep vein thrombosis, pulmonary embolism and etc.Complications will be categorized using the Dindo surgical complication grading scale.
Time Frame
Up to 6 weeks.
Title
•Change from baseline in PFIQ-7 scores.
Time Frame
1 year, 2 years and 3 years.
Title
•In subjects sexually active at baseline, assessment of sexual function using PISQ-12 (mean scores and change from baseline)
Time Frame
1 year, 2 years and 3 years.
Title
•Subject global impression assessed on a 5 point Likert scale
Time Frame
1 year, 2 years and 3 years.
Title
•Presence/absence of complications (composite score)
Description
Long-term negative outcomes of the surgical procedure will also be recorded until 3 years after surgery. For example, mesh erosion, de novo urinary incontinence, de novo dyspareunia and overall failure rate. Complications will be categorized using the Dindo surgical complication grading scale.
Time Frame
Up to 3 years.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Candidates with symptomatic pelvic organ prolapse of POP-Q Stage III, suitable for surgical repair. Vaginal hysterectomy and anti-incontinence procedures could be performed concurrently. Age ≥ 55 years. Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires. Exclusion Criteria: Previous repair of pelvic organ prolapse involving insertion of mesh. Experimental drug or experimental medical device within 3 months prior to the planned procedure. Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared. Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery. History of chemotherapy or pelvic radiation therapy. Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease, multiple sclerosis, spinal cord injury or trauma). Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis, endometriosis, coccydynia, vulvodynia). Nursing or pregnant or intends future pregnancy. Chronic cough not well-controlled. BMI ≥ 30. In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lan Zhu
Phone
13911714696
Email
zhu_julie@sina.com
First Name & Middle Initial & Last Name or Official Title & Degree
Juan Chen
Phone
13521354364
Email
pumchcj@sina.com
Facility Information:
Facility Name
Foshan Maternal and Child Health Hospital
City
Foshan
State/Province
Guangdong
ZIP/Postal Code
528000
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yuling Wang
Phone
13049161630
Email
Wujun701121@126.com
Facility Name
Peking University Shenzhen Hospital
City
Shenzhen
State/Province
Guangdong
ZIP/Postal Code
518036
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Huan Li
Phone
13828700921
Email
szbdlh@163.com
Facility Name
the Third Affiliated Hospital of Zhengzhou University
City
Zhengzhou
State/Province
Henan
ZIP/Postal Code
450052
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luwen Wang
Phone
13607683293
Email
Wangluwen_688@sohu.com
Facility Name
Affiliated Shengjing Hospital of China Medical University
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110004
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhijun Xia
Phone
13840118800
Email
xiazhijunhosp2@sina.com
Facility Name
Peking Union Medical College Hospital
City
Beijing
ZIP/Postal Code
100730
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Juan Chen
Phone
13521354364
Email
pumchcj@sina.com

12. IPD Sharing Statement

Learn more about this trial

Ischia Spinous Fascia Fixation Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Pelvic Organ Prolapse Stage III

We'll reach out to this number within 24 hrs